Literature DB >> 10922494

Identification of group X secretory phospholipase A(2) as a natural ligand for mouse phospholipase A(2) receptor.

Y Yokota1, K Higashino, K Nakano, H Arita, K Hanasaki.   

Abstract

Phospholipase A(2) receptor (PLA(2)R) mediates various biological responses elicited by group IB secretory phospholipase A(2) (sPLA(2)-IB). The recently cloned group X sPLA(2) (sPLA(2)-X) possesses several structural features characteristic of sPLA(2)-IB. Here, we detected a specific binding site of sPLA(2)-X in mouse osteoblastic MC3T3-E(1) cells. Cross-linking experiments demonstrated its molecular weight (180 kDa) to be similar to that of PLA(2)R. In fact, sPLA(2)-X was found to bind the recombinant PLA(2)R expressed in COS-7 cells, and its specific binding detected in mouse lung membranes was abolished by the deficiency of PLA(2)R. These findings demonstrate sPLA(2)-X to be one of the high-affinity ligands for mouse PLA(2)R.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10922494     DOI: 10.1016/s0014-5793(00)01848-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Group X secretory phospholipase A2 enhances TLR4 signaling in macrophages.

Authors:  Preetha Shridas; William M Bailey; Kayla R Talbott; Rob C Oslund; Michael H Gelb; Nancy R Webb
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

2.  The dual role of group V secretory phospholipase A2 in pancreatic β-cells.

Authors:  Preetha Shridas; Victoria P Noffsinger; Andrea C Trumbauer; Nancy R Webb
Journal:  Endocrine       Date:  2017-08-19       Impact factor: 3.633

3.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

4.  Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.

Authors:  Liyo Kao; Vinson Lam; Meryl Waldman; Richard J Glassock; Quansheng Zhu
Journal:  J Am Soc Nephrol       Date:  2014-09-09       Impact factor: 10.121

5.  Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.

Authors:  K Sonoki; M Iwase; N Sasaki; S Ohdo; S Higuchi; Y Takata; M Iida
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

6.  sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor.

Authors:  Yangbin Pan; Jianxin Wan; Yipeng Liu; Qian Yang; Wei Liang; Pravin C Singhal; Moin A Saleem; Guohua Ding
Journal:  Sci Rep       Date:  2014-10-22       Impact factor: 4.379

7.  A cohort study of membranous nephropathy, primary or secondary.

Authors:  Maryam Arghiani; Boshra Hasan Zamani; Fatemeh Nazemian; Sara Samadi; Malihe Saber Afsharian; Mahmoud Habibzadeh; Saeid Eslami; Mahin Ghorban Sabbagh
Journal:  BMC Nephrol       Date:  2021-04-19       Impact factor: 2.388

8.  Treatment of Mouse Sperm with a Non-Catalytic Mutant of PLA2G10 Reveals That PLA2G10 Improves In Vitro Fertilization through Both Its Enzymatic Activity and as Ligand of PLA2R1.

Authors:  Roland Abi Nahed; Magali Dhellemmes; Christine Payré; Emilie Le Blévec; Jean-Philippe Perrier; Sylviane Hennebicq; Jessica Escoffier; Pierre F Ray; Corinne Loeuillet; Gérard Lambeau; Christophe Arnoult
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

Review 9.  Immune-Monitoring Disease Activity in Primary Membranous Nephropathy.

Authors:  Paolo Cravedi; Marta Jarque; Andrea Angeletti; Àlex Favà; Chiara Cantarelli; Oriol Bestard
Journal:  Front Med (Lausanne)       Date:  2019-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.